Keren Farin

Keren Farin has extensive work experience in the field of intellectual property. Keren started their career as a Patent Attorney at Geyra Gassner | IP Law in 2015 and worked there until 2017. Keren then joined Ingenium IP Israel as an IP Consultant from 2017 to 2020. In the same year, they also worked as an IP Manager at Inovytec Medical Solutions Ltd. In 2019, they joined MIGAL Galilee Research Institute as an IP Manager and later moved to EdiTy Therapeutics in 2020 for the same role. Since 2017, they have been working independently as an Intellectual Property Consultant. Keren's most recent position is as the VP of Intellectual Property at Emendo Biotherapeutics, which they have held since December 2021.

Keren Farin holds a B.Sc. degree in Biotechnology Engineering, which was obtained from Ben-Gurion University of the Negev between the years 2000 and 2004. Subsequently, they pursued a PhD in Neurobiology at Tel Aviv University from 2005 to 2011. In terms of additional certifications, they obtained a Clinical Research Associate Certification (CRA) from pharma-job biomedical college in June 2010. Keren also holds a Patent Attorney certification from the Israel Patent Office, although the specific dates of obtaining this certification are not provided.